The objective of this study is to evaluate effectiveness and safety of XIENCE PRIME stent in the "real world" daily practice as compared with other drug eluting stents (DESs)
This study is a non-randomized, prospective, open-label registry to compare the effectiveness and safety of XIENCE PRIME stents versus other DESs in patients with coronary artery disease.
Study Type
OBSERVATIONAL
Enrollment
2,000
composite of death, nonfatal myocardial infarction (MI), or target- Vessel Revascularization (TVR)
Time frame: 12 months post procedure
Death (all cause and cardiac)
Time frame: one month
Death (all cause and cardiac)
Time frame: 6 months
Death (all cause and cardiac)
Time frame: yearly up to 5 years
MI
Time frame: one month
MI
Time frame: 6 months
MI
Time frame: yearly up to 5 years
Composite of death or MI
Time frame: one month
Composite of death or MI
Time frame: 6 months
Composite of death or MI
Time frame: yearly up to 5 years
Composite of cardiac death or MI
Time frame: one month
Composite of cardiac death or MI
Time frame: 6 months
Composite of cardiac death or MI
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hallym University Sacred Heart Hospital
Anyang, South Korea
Soonchunhyang Univ. Bucheon Hospital
Bucheon-si, South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, South Korea
Gangwon National Univ. Hospital
Chuncheon, South Korea
Daegu Catholic University Medical Center
Daegu, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, South Korea
Gangneung Asan Hospital
Gangneung, South Korea
Chonnam National University Hospital
Gwangju, South Korea
National Health Insurance Corporation Ilsan Hospital
Ilsan, South Korea
...and 19 more locations
Time frame: yearly up to 5 years
TVR
Time frame: one month
TVR
Time frame: 6 months
TVR
Time frame: yearly up to 5 years
Target-lesion revascularization (TLR)
Time frame: one month
Target-lesion revascularization (TLR)
Time frame: 6 months
Target-lesion revascularization (TLR)
Time frame: yearly up to 5 years
Stent thrombosis (ARC criteria)
Time frame: one month
Stent thrombosis (ARC criteria)
Time frame: 6 months
Stent thrombosis (ARC criteria)
Time frame: yearly up to 5 years
Procedural success (defined as achievement of a final diameter stenosis of <30% by visual estimation, without the occurrence of death, Q-wave MI, or urgent revascularization during the index hospitalization)
Time frame: At discharge from the index hospitalization